-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
A challenging case of candida parapsilosis keratitis
Ping Guo, Jiaming Wang, Hongbin Xie, Baotao Lin, Ming Li, Zhongliang Zou, Yuan Zhang, Yingting Zhu and Ahmad Kheirkhah
Case Report: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations
Tamar Plitt & Dmitriy Zamarin
Clinical Trail Outcomes: Clinical Investigation
-
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
Graham W Warren
Commentary: Clinical Investigation
-
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
Graham W Warren
Commentary: Clinical Investigation
-
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
Graham W Warren
Commentary: Clinical Investigation
-
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
Graham W Warren
Commentary: Clinical Investigation
-
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
Graham W Warren
Commentary: Clinical Investigation
-
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
Graham W Warren
Commentary: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Agalsidase alfa for the treatment of fabry disease: a closer look
Shawn E Lipinski, Edina Komlodi-Pasztor & Ozlem Goker-Alpan
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gene therapy in neurology: review of ongoing clinical trials
Maria Judit Molnar,George Nemeth
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gene therapy in neurology: review of ongoing clinical trials
Maria Judit Molnar,George Nemeth
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gene therapy in neurology: review of ongoing clinical trials
Maria Judit Molnar,George Nemeth
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gene therapy in neurology: review of ongoing clinical trials
Maria Judit Molnar,George Nemeth
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gene therapy in neurology: review of ongoing clinical trials
Maria Judit Molnar,George Nemeth
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gene therapy in neurology: review of ongoing clinical trials
Maria Judit Molnar,George Nemeth
Review: Clinical Trail Outcomes: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Strategies to treat sepsis: old and new
Steven P LaRosa, Steven M Opal
Therapeutic Prospective: Clinical Investigation
-
Strategies to treat sepsis: old and new
Steven P LaRosa, Steven M Opal
Therapeutic Prospective: Clinical Investigation
-
Strategies to treat sepsis: old and new
Steven P LaRosa, Steven M Opal
Therapeutic Prospective: Clinical Investigation
-
Strategies to treat sepsis: old and new
Steven P LaRosa, Steven M Opal
Therapeutic Prospective: Clinical Investigation
-
Strategies to treat sepsis: old and new
Steven P LaRosa, Steven M Opal
Therapeutic Prospective: Clinical Investigation
-
Strategies to treat sepsis: old and new
Steven P LaRosa, Steven M Opal
Therapeutic Prospective: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation